SCHEMBL742939

SCHEMBL742939

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccc(CN4CCCCC4)cc3)n[nH]c2s1)c1cccc(F)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.64
BCR P11274 2/20 0.64
CYP2C9 P11712 1/20 0.46
AURKA O14965 1/20 0.44
HRH3 Q9Y5N1 2/20 0.41
ALK Q9UM73 1/20 0.38
KDR P35968 1/20 0.38
MPO P05164 1/20 0.38
ACKR3 P25106 1/20 0.38
WNT1 P04628 1/20 0.38
DYRK1A Q13627 1/20 0.38
CCR2 P41597 1/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NTRK1 P04629 1/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
RAB9A P51151 1/20 0.38
KIT P10721 1/20 0.37
FLT3 P36888 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740581 0.99 ABL1 (0.63) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL741731 0.98 ABL1 (0.61) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL742340 0.93 ABL1 (0.55) ABL1BCRAURKAALKKDR
SCHEMBL742456 0.92 ABL1 (0.65) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL740752 0.92 ABL1 (0.76) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL741183 0.92 ABL1 (0.76) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL742130 0.92 ABL1 (0.64) ABL1BCRCYP2C9AURKAKDR
SCHEMBL742638 0.91 ABL1 (0.74) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL742951 0.90 ABL1 (0.62) ABL1BCRCYP2C9AURKAKDR
SCHEMBL743126 0.90 ABL1 (0.62) ABL1BCRCYP2C9AURKAHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
EP-2007380-B1 USE OF A KINASE INHIBITOR FOR THE TREATMENT OF PARTICULAR RESISTANT TUMORS NERVIANO MEDICAL SCIENCES SRL (IT) 2011-09-14 EP claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed
EP-2007380-B1 USE OF A KINASE INHIBITOR FOR THE TREATMENT OF PARTICULAR RESISTANT TUMORS NERVIANO MEDICAL SCIENCES SRL (IT) 2011-09-14 EP disclosed